These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial (author's transl)]. Bode JC, Schmidt U, Dürr HK. Med Klin; 1977 Mar 25; 72(12):513-8. PubMed ID: 840125 [Abstract] [Full Text] [Related]
8. [Treatment of subacute and chronic forms of hepatitis as well as of chronic degenerative liver diseases using Silymarin]. Zirm KL. Wien Med Wochenschr; 1973 May 12; 123(19):302-5. PubMed ID: 4702588 [No Abstract] [Full Text] [Related]
9. [Influence of (+)-cyanidanol-3 on acute hepatitis. Results of a double blind study (author's transl)]. Rehmann I, Heinkel K. Med Klin; 1977 Dec 16; 72(50):2159-64. PubMed ID: 339045 [Abstract] [Full Text] [Related]
10. [The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis (author's transl)]. Benda L, Dittrich H, Ferenzi P, Frank H, Wewalka F. Wien Klin Wochenschr; 1980 Oct 10; 92(19):678-83. PubMed ID: 7008367 [Abstract] [Full Text] [Related]
11. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases]. Fehér J, Deák G, Müzes G, Láng I, Niederland V, Nékám K, Kárteszi M. Orv Hetil; 1989 Dec 17; 130(51):2723-7. PubMed ID: 2574842 [Abstract] [Full Text] [Related]
12. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial. Gharagozloo M, Moayedi B, Zakerinia M, Hamidi M, Karimi M, Maracy M, Amirghofran Z. Fundam Clin Pharmacol; 2009 Jun 17; 23(3):359-65. PubMed ID: 19453758 [Abstract] [Full Text] [Related]
13. Immunomodulatory and hepatoprotective effects of in vivo treatment with free radical scavengers. Láng I, Nékám K, Deák G, Müzes G, Gonzales-Cabello R, Gergely P, Csomós G, Fehér J. Ital J Gastroenterol; 1990 Oct 17; 22(5):283-7. PubMed ID: 1983711 [Abstract] [Full Text] [Related]
15. [Controlled study of the effect of silymarin on alcoholic liver disease]. Bunout D, Hirsch S, Petermann M, de la Maza MP, Silva G, Kelly M, Ugarte G, Iturriaga H. Rev Med Chil; 1992 Dec 17; 120(12):1370-5. PubMed ID: 1343377 [Abstract] [Full Text] [Related]
17. Oral silymarin for chronic hepatitis C - a retrospective analysis comparing three dose regimens. Huber R, Futter I, Lüdtke R. Eur J Med Res; 2005 Feb 28; 10(2):68-70. PubMed ID: 15817425 [Abstract] [Full Text] [Related]
18. Hepatoprotective and immunological effects of antioxidant drugs. Láng I, Nékám K, González-Cabello R, Mũzes G, Gergely P, Fehér J. Tokai J Exp Clin Med; 1990 May 28; 15(2-3):123-7. PubMed ID: 1983370 [Abstract] [Full Text] [Related]